Wasn't guidance $8-11m?
"Forecast cash outflow for the March 2024 quarter is expected to be $8 - $11m (including R&D refund) and the June 2024 quarter expected to be in the $6m - $8m range which is inclusive of phase 3 stage 2 restart costs." (December qtrly)
Hopefully the final upfront cash flows with trials reiterated in the recent quarterly flowing out early in the quarter and nothing more....
Wasn't guidance $8-11m?"Forecast cash outflow for the March 2024...
-
- There are more pages in this discussion • 46 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
20.0¢ |
Change
-0.015(6.98%) |
Mkt cap ! $70.04M | |||
| Open | High | Low | Value | Volume |
| 21.0¢ | 21.0¢ | 20.0¢ | $201.6K | 994.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 15 | 429247 | 20.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 21.0¢ | 13806 | 2 |
View Market Depth
| Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
| PAR (ASX) Chart |